LifeVantage Announces Financial Results for the Second Quarter of Fiscal 2026

About this update from Lifevantage Corporation

[{"type":"image","alt":"LifeVantage Corporation","displaySize":"","headline":null,"caption":"LifeVantage Corporation","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":232,"url":"https://media.zenfs.com/en/globenewswire.com/cd534d51d829d7b3339619eb875e1ea1"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/i6URalUjQY2zzRFuP04k0Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTMyNTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/cd534d51d829d7b3339619eb875e1ea1","width":300,"height":232}},"lazy":false},{"type":"text","content":"Announces New $60 Million Share Repurchase Authorization","length":56,"tagName":"p"},{"type":"text","content":"SALT LAKE CITY, Feb. 04, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its second fiscal quarter ended December 31, 2025.","length":298,"tagName":"p"},{"type":"text","content":"Second Quarter Fiscal 2026 Summary*:","length":36,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Revenue was $48.9 million, a decrease of 27.8% from the prior year period. Revenue was up 2.9% sequentially from the first quarter.","length":131,"tagName":"p"}]},{"val":[{"type":"text","content":"Revenue in the Americas decreased 32.6%, and revenue in Asia/Pacific & Europe decreased 2.1%.","length":97,"tagName":"p"}]},{"val":[{"type":"text","content":"Net income per diluted share was $0.02, versus $0.19 per diluted share a year ago;","length":82,"tagName":"p"}]},{"val":[{"type":"text","content":"Adjusted earnings per diluted share was $0.15, compared to $0.22 a year ago; and","length":80,"tagName":"p"}]},{"val":[{"type":"text","content":"Adjusted EBITDA was $3.9 million compared to $6.5 million a year ago.","length":69,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":459,"olType":false},{"type":"text","content":"* All comparisons are on a year over year basis and compare the second quarter of fiscal 2026 to the second quarter of fiscal 2025, unless otherwise noted.","length":155,"tagName":"p"},{"type":"text","content":""The second quarter reflected challenging competitive dynamics in the weight loss market as we cycled the launch of our MindBody GLP-1 System™ in October 2024," said Steve Fife, Pre...

More updates from Lifevantage Corporation